On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. Experts emphasized ...

YolTech Therapeutics CEO and founder Dr Yuxuan Wu said: "The initiation of the clinical trial for YOLT-204 represents a ...

YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204 , an investigational ...

It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex Pharmaceuticals a significant new revenue source beyond cystic fibrosis, especially as ...

The beta test for Elden Ring Nightreign is scheduled for February 14 through 16, but only during select time periods. Step 1: Visit the official Elden Ring Nightreign site starting on January 10.

The companies will focus on next-generation gene therapies for sickle cell disease and transfusion-dependent beta thalassemia. Credit: da-kuk via Getty Images ... editing them in a laboratory using ...

Generation Beta is starting and entering into a world with AI, including the potential for ... [+] artificial general intelligence (AGI) and the vaunted artificial superintelligence (ASI).

In a historic moment for India, the country welcomed its first ‘Generation Beta’ baby as a boy was born at Synod Hospital in Aizawl, the capital of Manipur’s northeastern state, shortly ...